Literature DB >> 18651625

Group efficiency: a guideline for hits-to-leads chemistry.

Marcel L Verdonk1, David C Rees.   

Abstract

Mesh：

Year:  2008        PMID： 18651625     DOI： 10.1002/cmdc.200800132

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  16 in total

1.  The flow synthesis of heterocycles for natural product and medicinal chemistry applications.

Authors:  Marcus Baumann; Ian R Baxendale; Steven V Ley
Journal:  Mol Divers       Date:  2010-10-20       Impact factor: 2.943

2.  Assessing the lipophilicity of fragments and early hits.

Authors:  Paul N Mortenson; Christopher W Murray
Journal:  J Comput Aided Mol Des       Date:  2011-05-26       Impact factor: 3.686

Review 3.  The role of ligand efficiency metrics in drug discovery.

Authors:  Andrew L Hopkins; György M Keserü; Paul D Leeson; David C Rees; Charles H Reynolds
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

4.  Ligand efficiency metrics considered harmful.

Authors:  Peter W Kenny; Andrei Leitão; Carlos A Montanari
Journal:  J Comput Aided Mol Des       Date:  2014-06-05       Impact factor: 3.686

5.  Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure.

Authors:  Marion Lanier; Jason Pickens; Simone V Bigi; Erica L Bradshaw-Pierce; Alison Chambers; Zacharia S Cheruvallath; Derek Cole; Douglas R Dougan; Jacques Ermolieff; Tony Gibson; Petro Halkowycz; Aki Hirokawa; Anthony Ivetac; Joanne Miura; Evan Nunez; Mark Sabat; John Tyhonas; Haixia Wang; Xiaolun Wang; Steve Swann
Journal:  ACS Med Chem Lett       Date:  2017-02-08       Impact factor: 4.345

6.  Biophysical limits of protein-ligand binding.

Authors:  Richard D Smith; Alaina L Engdahl; James B Dunbar; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2012-07-18       Impact factor: 4.956

7.  Discovery of fragment molecules that bind the human peroxiredoxin 5 active site.

Authors:  Sarah Barelier; Dominique Linard; Julien Pons; André Clippe; Bernard Knoops; Jean-Marc Lancelin; Isabelle Krimm
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

8.  Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.

Authors:  Madeline E Kavanagh; Anthony G Coyne; Kirsty J McLean; Guy G James; Colin W Levy; Leonardo B Marino; Luiz Pedro S de Carvalho; Daniel S H Chan; Sean A Hudson; Sachin Surade; David Leys; Andrew W Munro; Chris Abell
Journal:  J Med Chem       Date:  2016-03-22       Impact factor: 7.446

9.  Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.

Authors:  Ishrat Jabeen; Karin Pleban; Uwe Rinner; Peter Chiba; Gerhard F Ecker
Journal:  J Med Chem       Date:  2012-03-27       Impact factor: 7.446

10.  Optimization of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase Based on Group Efficiency Analysis.

Authors:  Alvin W Hung; H Leonardo Silvestre; Shijun Wen; Guillaume P C George; Jennifer Boland; Tom L Blundell; Alessio Ciulli; Chris Abell
Journal:  ChemMedChem       Date:  2015-10-21       Impact factor: 3.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.